Retinoblastoma in Central America: Report from the Central American Association of Pediatric Hematology Oncology (AHOPCA)

Pediatric Blood and Cancer

Volumn 58, Issue 4, 2012, Pages 545-550

  Luna Fineman, Sandra ^a,b   Barnoya, Margarita ^b   Bonilla, Miguel ^c   Fu, Ligia ^d   Baez, Fulgencio ^e   Rodríguez Galindo, Carlos ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Unidad Nacional de Oncologia Pediatrica   (Guatemala)

^c Hospital Benjamin Bloom   (El Salvador)

^d Hospital Escuela Materno Infantil   (Honduras)

^e Hospital La Mascota   (Nicaragua)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Low income countries; Malignancies; Pediatric oncology; Retinoblastoma

Indexed keywords

CARBOPLATIN; CYTARABINE; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

ARTICLE; BUPHTHALMOS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CENTRAL AMERICA; CHILD; CLINICAL TRIAL; CRYOTHERAPY; ENUCLEATION; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINOBLASTOMA; TREATMENT OUTCOME; TREATMENT REFUSAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CENTRAL AMERICA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ETOPOSIDE; EYE NEOPLASMS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; RETINOBLASTOMA; SURVIVAL RATE; VINCRISTINE;

EID: 84856611134     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23307     Document Type: Article

References (18)

1. Devesa S. The incidence of retinoblastoma. Am J Ophthalmol 1975; 80: 263-265.
2. Chantada G, Fandiño A, Manzitti J, et al. Late diagnosis of retinoblastoma in a developing country. Arch Dis Child 1999; 80: 171-174.
3. Leal-Leal C, Rivera-Luna R, Tovar-Guzmán V, et al. Risk of dying of retinoblastoma in Mexican children. Med Pediatr Oncol 2002; 38: 211-213.
4. Howard SC, Marinoni M, Castillo L, et al. Improving outcomes for children with cancer in low-income countries in Latin America: A report of the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part 1. Pediatr Blood Cancer 2007; 48: 364-369.
5. Howard S, Ortiz R, Baez LF, et al. Protocol-based treatment for children with cancer in low-income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part II. Pediatr Blood Cancer 2007; 48: 486-490.
6. Pratt CB, Fontanesi J, Lu X, et al. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist 1997; 2: 1-5.
7. Peto R, Peto J. Asymtotical efficient rank in variant test procedures. JR ST Soc (A) 1972; 135: 158.
8. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. de Aguirre Neto JC, Antoneli CB, Ribeiro KB, et al. Retinoblastoma in children older than 5 years of age. Pediatr Blood Cancer 2007; 48: 292-295.
10. Ozdemir H, Tacyildiz N, Unal E, et al. Clinical and epidemiological characteristics of retinoblastoma: Correlation with prognosis in a Turkish pediatric oncology center. Pediatr Hematol Oncol 2007; 24: 221-231.
11. Leal-Leal C, Flores-Rojo M, Medina-Sansón A, et al. A multicenter report from the Mexican Retinoblastoma Group. Br J Ophthalmol 2004; 88: 1074-1077.
12. Sahu S, Banavali SD, Pai SK, et al. Retinoblastoma: Problems and perspectives from India. Pediatr Hematol Oncol 1998; 15: 501-508.
13. Luna-Fineman S, Antillon-Klussman F, Valverde-Gonzalez P, et al. Pediatric oncology unit in Guatemala. SIOP 2002; 492.
14. Bonilla M, Rossell N, Salaverria C, et al. Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer 2009; 125: 2144-2146.
15. Metzger M, Howard S, Fu L, et al. Outcome of childhood acute lymphoblastic leukemia in resource-poor countries. Lancet 2003; 362: 706-708.
16. Sitorus RS, Moll AC, Suhardjono S, et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet 2009; 30: 31-36.
17. Leander C, Fu LC, Peña A, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer 2007; 49: 817-819.
18. Wilimas JA, Wilson MW, Haik BG, et al. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer 2009; 53: 42-46.